Monday, December 14, 1998
Ag play may stand out
While the pharmaceutical might of Aventis is open to question, there is more optimism about the prospects for Aventis's crop protection business created by the merger of AgrEvo - the 60:40 Hoechst-Schering joint venture - and Rhone-Poulenc Ag.
AgrEvo already was considered one of the "haves" in the burgeoning agbio business (see BioCentury, Oc.t. 12), while Rhone-Poulenc was labeled a "have-not" with some interesting technology that could make it